Efficacy of gemcitabine and cetuximab combination treatment in head and neck squamous cell carcinoma

By            

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 918-924

Spandidos Publications

Access to resources Recommend Favorite

Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck

By Lathers D.M.R.   Achille N.J.   Young M.R.I.  

Human Immunology, Vol. 64, Iss. 12, 2003-12 ,pp. : 1160-1166

Elsevier

Access to resources Recommend Favorite

Molecular-targeted therapy hypoxia in head and neck squamous cell carcinoma patients (Review)

By Adachi   Thomas  

Molecular and Clinical Oncology, Vol. 1, Iss. 1, 2013-01 ,pp. : 12-14

Spandidos Publications

Access to resources Recommend Favorite

Immunological Approach in the Evaluation of Regional Lymph Nodes of Patients with Squamous Cell Carcinoma of the Head and Neck

By Verastegui E.   Morales R.   Barrera J.L.   Müeller A.   Hadden J.   Guzman B.   Meneses A.   Alfaro G.  

Clinical Immunology, Vol. 102, Iss. 1, 2002-01 ,pp. : 37-47

Academic Press

Access to resources Recommend Favorite

Expression and Prognostic Relevance of GAGE1 and XAGE1 Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma

By  

Current Molecular Medicine, Vol. 17, Iss. 10, 2018-05 ,pp. : 707-717

Bentham Science Publishers

Access to resources Recommend Favorite